Cyclacel Pharma (CYCC) Reports Q3 Loss of $0.08/Share

Cyclacel Pharma (NASDAQ: CYCC) reported Q3 EPS of ($0.08), versus ($0.22) reported last year.

For earnings history and earnings-related data on Cyclacel Pharma (CYCC) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Credo Technology pops 3.5% as Evercore initiates with monster $325 price target
• Stifel Reiterates Buy Rating on FedEx (FDX) Ahead of Q4 Earnings